Creative Planning Age X Therapeutics, Inc. Transaction History

Creative Planning

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.33 - $0.74 $66 - $148	-200 Reduced 0.28%	70,700 $26,000
Q3 2023 Nov 16, 2023	SELL	$0.67 - $0.85 $301 - $382	-450 Reduced 0.63%	70,900 $48,000
Q2 2023 Jul 21, 2023	SELL	$0.45 - $0.89 $454 - $898	-1,010 Reduced 1.4%	71,350 $63,000
Q2 2022 Aug 15, 2022	BUY	$0.57 - $1.0 $11,399 - $20,000	20,000 Added 38.2%	72,360 $42,000
Q1 2022 May 16, 2022	BUY	$0.65 - $1.2 $13,130 - $24,240	20,200 Added 62.81%	52,360 $45,000
Q4 2021 Feb 11, 2022	BUY	$0.53 - $1.09 $265 - $545	500 Added 1.58%	32,160 $35,000
Q3 2021 Nov 10, 2021	BUY	$0.93 - $1.54 $1,041 - $1,724	1,120 Added 3.67%	31,660 $30,000
Q2 2021 Aug 04, 2021	SELL	$1.14 - $1.77 $151 - $235	-133 Reduced 0.43%	30,540 $47,000
Q1 2021 Apr 30, 2021	BUY	$1.56 - $2.7 $47,849 - $82,817	30,673 New	30,673 $50,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.